Back to mobile site

Crescita shareholders approve $0.80 per share acquisition by ClinActiv

May 14, 2026 1:48 PM EDT Send to a Friend
Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) announced that shareholders voted to approve the acquisition by ClinActiv Holdings ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login